Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Mismetti

Showing results (161-170 of 180) with videos related to

Pageof 18
Sort By:
Bulletin Du Cancer|August 30, 2008
[2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients]Philippe Debourdeau, Dominique Farge-Bancel, Lise Bosquet, et al.
Presse Medicale (Paris, France : 1983)|January 17, 2009
[Recommendations for venous thromboembolic events treatment and central venous catheter thrombosis management in cancer patients]Antoine Elias, Philippe Debourdeau, Jean Marc Renaudin, et al.
Journal Des Maladies Vasculaires|November 15, 2008
[2008 Standards, Options: Recommendations for venous thromboembolic events(VTE)treatment and central venous catheter thrombosis(CVCT) management in cancer patients], Isabelle Mahé, Ismail Elalamy, et al.
Thrombosis Research|October 8, 2023
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trialGeoffroy Rambaud, Vicky Mai, Camille Motreff, et al.
Annales Francaises D'Anesthesie Et De Reanimation|July 23, 2008
[Standards, Options: recommendations 2008; thromboembolic events treatment, prophylaxis and treatment of central venous catheter thrombosis in patients with cancer]Irène Kriegel, Eric Desruennes, Marie-Cécile Douard, et al.
JAMA|July 8, 2015
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical TrialFrancis Couturaud, Olivier Sanchez, Gilles Pernod, et al.
Thrombosis and Haemostasis|June 24, 2019
Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE TrialLeela Raj, Philippe Robin, Raphael Le Mao, et al.
JAMA|January 5, 2021
Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory SymptomsFrancis Couturaud, Laurent Bertoletti, Jean Pastre, et al.
Chest|October 10, 2021
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized TrialBenjamin Planquette, Laurent Bertoletti, Anaïs Charles-Nelson, et al.
The American Journal of Medicine|April 26, 2020
Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trialLeela Raj, Emilie Presles, Raphael Le Mao, et al.
Pageof 18

Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Bulletin Du Cancer|August 30, 2008
[2008 Standards, Options: recommendations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients]Philippe Debourdeau, Dominique Farge-Bancel, Lise Bosquet, et al.
Presse Medicale (Paris, France : 1983)|January 17, 2009
[Recommendations for venous thromboembolic events treatment and central venous catheter thrombosis management in cancer patients]Antoine Elias, Philippe Debourdeau, Jean Marc Renaudin, et al.
Journal Des Maladies Vasculaires|November 15, 2008
[2008 Standards, Options: Recommendations for venous thromboembolic events(VTE)treatment and central venous catheter thrombosis(CVCT) management in cancer patients], Isabelle Mahé, Ismail Elalamy, et al.
Thrombosis Research|October 8, 2023
Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: Post-hoc analysis of the PEP trialGeoffroy Rambaud, Vicky Mai, Camille Motreff, et al.
Annales Francaises D'Anesthesie Et De Reanimation|July 23, 2008
[Standards, Options: recommendations 2008; thromboembolic events treatment, prophylaxis and treatment of central venous catheter thrombosis in patients with cancer]Irène Kriegel, Eric Desruennes, Marie-Cécile Douard, et al.
JAMA|July 8, 2015
Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical TrialFrancis Couturaud, Olivier Sanchez, Gilles Pernod, et al.
Thrombosis and Haemostasis|June 24, 2019
Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE TrialLeela Raj, Philippe Robin, Raphael Le Mao, et al.
JAMA|January 5, 2021
Prevalence of Pulmonary Embolism Among Patients With COPD Hospitalized With Acutely Worsening Respiratory SymptomsFrancis Couturaud, Laurent Bertoletti, Jean Pastre, et al.
Chest|October 10, 2021
Rivaroxaban vs Dalteparin in Cancer-Associated Thromboembolism: A Randomized TrialBenjamin Planquette, Laurent Bertoletti, Anaïs Charles-Nelson, et al.
The American Journal of Medicine|April 26, 2020
Evaluation of Venous Thromboembolism Recurrence Scores in an Unprovoked Pulmonary Embolism Population: A Post-hoc Analysis of the PADIS-PE trialLeela Raj, Emilie Presles, Raphael Le Mao, et al.
Pageof 18